Wilmer Cutler Pickering Hale and Dorr represented Magnet Biomedicine in the transaction. Magnet Biomedicine, a leading biopharmaceutical company, announced a collaboration and license agreement with Eli...
Magnet Biomedicine’s Collaboration and License Agreement with Lilly
WEX’s $250 Million Acquisition of Payzer
Wilmer Cutler Pickering Hale and Dorr is representing WEX in the transaction. WEX (NYSE: WEX) announced the signing of a definitive agreement to acquire Payzer. Pursuant to...